Industries > Pharma > Anti-snoring Market Report to 2031
Anti-snoring Market Report to 2031
By Device (Mandibular Advancement Devices, Nasal Devices, Continuous Positive Airway Devices, Others), By Surgery (Radiofrequency Palatoplasty, Uvulopalatopharyngoplasty (UPPP), Tonsillectomy, Laser-Assisted Uvulopalatoplasty, Others) By End User (Hospitals, Retail Pharmacies, Others) And Leading Regional/Country Market Analysis
Global Anti-Snoring Treatment Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Global Anti-Snoring Treatment market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our Global Anti-Snoring Treatment report provides tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Global Anti-Snoring Treatment Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and commercial developments.
Anti-Snoring Treatment Market by Devices
• Mandibular Advancement devices
• Tongue Stabilizing Devices
• Continuous Positive Airway Devices
• Others
Anti-Snoring Treatment Market by Surgery
• Radiofrequency Palatoplasty
• Uvulopalatopharyngoplasty (UPPP)
• Tonsillectomy
• Laser-assisted Uvulopalatoplasty
• Others
Anti-Snoring Treatment Market by End User
• Hospitals
• Retail Pharmacies
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Japan
o Rest of Asia Pacific
• Latin America
o Rest of Latin America
• Middle East and Africa
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Global Anti-Snoring Treatment Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Global Anti-Snoring Treatment Market with forecasts By device, By Surgery, and End-User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Global Anti-Snoring Treatment Market report helps you
In summary, our 250+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Global Anti-Snoring Treatment Market, with forecasts by device, by Surgery, and by End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 20 key national markets – See forecasts for the Anti-Snoring Treatment market in North America, Europe, Asia-Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Rest of Asia Pacific, Latin America and Middle East and Africa, among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for Global Anti-Snoring Treatment of the major companies involved in the Anti-Snoring Treatment Market. Some of the company’s profiled in this report include-
• Apnea Sciences Corporation
• Medtronic Plc
• ASF Medical GmbH (Tomed GmbH)
• Fisher & Paykel Healthcare Limited
• Koninklijke Philips NV
• Meditas Ltd.
• Whole You Inc.
• ResMed Corp.
• SomnoMed Limited
• The Pure Sleep Company
• Theravent Inc.
• Medcaptain Medical
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the global anti-snoring treatment market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Anti-snoring Treatment Market Report to 2031: By Device (Mandibular Advancement Devices, Nasal Devices, Continuous Positive Airway Devices, Others), By Surgery (Radiofrequency Palatoplasty, Uvulopalatopharyngoplasty (UPPP), Tonsillectomy, Laser-Assisted Uvulopalatoplasty, Others) By End User (Hospitals, Retail Pharmacies, Others) And Leading Regional/Country Market Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Global Anti-Snoring Treatment Market
2.1. Anti-Snoring Treatment Market Definition
2.2. By devices Submarkets Definitions
2.3. By Surgery Submarkets Definitions
2.4. By End user Submarkets Definitions
3. Global Anti-Snoring Treatment Market Overview
3.1. Global Anti-Snoring Treatment Market Size and Forecast by Region
3.2. Global Anti-Snoring Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Advancement of Anti-Snoring Devices.
3.3.1.2. Increasing Incident and Prevalence Rate of Sleeping Disorders
3.3.1.3. Rising Obesity and Geriatric Population.
3.3.1.4. Excessive Consumption Smoking and Alcohol.
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of Anti-Snoring Devices and Surgery
3.3.2.2. Limited Efficacy of Current Snoring Treatments Available in the Market
3.3.3. Opportunities
3.3.3.1. Increasing Awareness About Sleep Apnea and Treatment.
3.3.3.2. Increasing Development of Anti-Snoring Treatment.
3.3.4. Porter’s Five Forces Analysis
3.3.4.1. Competitive Rivalry
3.3.4.2. Supplier Power
3.3.4.3. Buyer Power
3.3.4.4. Threat of Substitution
3.3.4.5. Threat of New Entry
4. Global Anti-Snoring Treatment Market Analysis and Forecast 2021-2031, By devices (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.2. Mandibular Advancement devices
4.3. Tongue Stabilizing Devices
4.4. Continuous Positive Airway Devices
4.5. Others
5. Global Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 By Surgery (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Radiofrequency Palatoplasty
5.1.1.1. Radiofrequency Palatoplasty Shrinks and Stiffens Soft Palate and Uvula.
5.1.2. Uvulopalatopharyngoplasty (UPPP)
5.1.2.1. Cost Effective Surgical Procedure.
5.1.3. Tonsillectomy
5.1.3.1. Increasingly Adopted Around the Globe to Treat Infection, Inflammation of the Tonsils and for Sleep Disorder.
5.1.4. Laser-assisted Uvulopalatoplasty
5.1.4.1. Prevents from Hospitalization and General Anesthesia
5.1.5. Others
6. Global Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 by End User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Hospitals
6.1.2. Retail Pharmacies
6.1.3. Others
7. North America Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Anti-Snoring Treatment Market Size and Forecast By devices
7.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
7.3. North America Anti-Snoring Treatment Market Size and Forecast By Surgery
7.3.1. Uvulopalatopharyngoplasty Submarket to Grow at Significant Rate
7.4. North America Anti-Snoring Treatment Market Size and Forecast by end user
7.4.1. Hospitals Submarket to Grow at Significant Rate
7.5. U.S. Anti-Snoring Treatment Market
7.5.1. Increasing Demand for Anti-Snoring Devices
7.6. Canada Anti-Snoring Treatment Market
8. Europe Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Anti-Snoring Treatment Market Size and Forecast By devices
8.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
8.3. Europe Anti-Snoring Treatment Market Size and Forecast By Application
8.3.1. Uvulopalatopharyngoplasty Submarket to Grow At Significant Rate
8.4. Europe Anti-Snoring Treatment Market Size and Forecast By End User
8.4.1. Hospitals Submarket to Grow at Significant Rate
8.5. UK Anti-Snoring Treatment Market
8.5.1. Increasing Demand for Anti-Snoring Devices in The Region
8.6. Germany Anti-Snoring Treatment Market
8.6.1. Rising Awareness for Snoring Treatment and Its Devices.
8.7. France Anti-Snoring Treatment Market
8.7.1. High Alcohol Consumption Rates in the Region.
8.8. Rest of Europe Anti-Snoring Treatment Market
9. Asia Pacific Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Anti-Snoring Treatment Market Size and Forecast By devices
9.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
9.3. Asia Pacific Anti-Snoring Treatment Market Size and Forecast By Surgery
9.3.1. Uvulopalatopharyngoplasty Submarket to Grow at Significant Rate
9.4. Asia Pacific Anti-Snoring Treatment Market Size and Forecast By End User
9.4.1. Increasing Adoption of Devices and Awareness About Sleep Apnea.
9.5. China Anti-Snoring Treatment Market
9.5.1. Prevalence of Smoking and Geriatric Population in the Region
9.6. India Anti-Snoring Treatment Market
9.6.1. Increasing Number of New Cancer Cases
9.7. Japan Anti-Snoring Treatment Market
9.7.1. Change in Lifestyle and Tobacco Smoking Contributing to Increase Anti-Snoring Treatment Demand.
9.8. Rest Of Asia Pacific Anti-Snoring Treatment Market
10. Latin America Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Anti-Snoring Treatment Market Size and Forecast By devices
10.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
10.3. Latin America Anti-Snoring Treatment Market Size and Forecast By Application
10.3.1. Uvulopalatopharyngoplasty Submarket to Grow at Significant Rate
10.4. Latin America Anti-Snoring Treatment Market Size and Forecast by End User
10.4.1. Brazil Anti-Snoring Treatment Market
10.4.1.1. Increasing Prevalence of Snoring in Older Population.
10.4.2. Mexico Anti-Snoring Treatment Market
10.4.2.1. High Prevalence of Snoring/Sleepiness/Observed Apneas in Mexican Population.
10.4.3. Rest Of Latin America Anti-Snoring Treatment Market
10.4.3.1. Increasing Demand for Anti-Snoring Devices.
11. MEA Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Anti-Snoring Treatment Market Size and Forecast By devices
11.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
11.3. MEA Anti-Snoring Treatment Market Size and Forecast By Application
11.3.1. Uvulopalatopharyngoplasty Submarket to Grow at Significant Rate
11.4. MEA Anti-Snoring Treatment Market Size and Forecast by end user
11.5. South Africa Anti-Snoring Treatment Market
11.5.1.1. High Consumption of Alcohol in The Region.
11.6. Rest Of MEA Anti-Snoring Treatment Market
11.6.1.1. Increasingly Healthcare Awareness and Demand for Devices.
12. Companies in the Anti-Snoring Treatment Market
12.1. Apnea Sciences Corporation
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2020)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2020
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2020)
12.2. Medtronic Plc
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2020)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2020
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2020)
12.3. ASF Medical GmbH (Tomed GmbH)
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2020)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2020
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2020)
12.4. Fisher & Paykel Healthcare Limited
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2020)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2020
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2020)
12.5. Koninklijke Philips NV
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2020)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2020
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2020)
12.6. Meditas Ltd
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2020)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2020
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2020)
12.7. Whole You Inc.
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2020)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2020
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2020)
12.8. ResMed Corp.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2020)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2020
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2020)
12.9. SomnoMed
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2020)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2020
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2020)
12.10. The Pure Sleep Company
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2020)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2020
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Anti-Snoring Treatment Market Drivers & Restraints 2021
Table 7. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49 Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 61. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 62. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 63. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 64. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 65. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 66. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 67. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 68. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 69. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 70. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 71. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 72. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 73. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 74. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 75. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 76. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 77. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 78. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 79. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 80. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 81. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 82. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 83. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 84. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 85. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 86. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 87. North America Anti-Snoring Treatment Market Forecast By devices2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 88. North America Anti-Snoring Treatment Market Forecast By devices2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 89. North America Anti-Snoring Treatment Market Forecast By devices2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 90. North America Anti-Snoring Treatment Market Forecast By devices2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 91. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 92. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 93. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 94. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 95. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 96. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 97. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031(US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 98. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 99. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 100. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 101. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 102. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 103. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 104. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 105. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 106. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 107. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 108. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 109. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 110. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 111. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 112. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 113. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 114. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario W)
Table 115. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 116. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 117. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 118. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 119. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 120. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 121. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 122. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 123. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 124. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 125. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 126. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 127. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 128. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 129. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 130. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 131. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 132. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 133. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 134. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 135. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 136. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 142. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 143. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 144. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 145. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 146. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 147. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 148. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR % CAGR %) (Before COVID)
Table 149. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR % CAGR %), (COVID - Scenario W)
Table 150. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 151. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 152. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 153. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 154. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR%, CAGR %) (COVID - Scenario W)
Table 155. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 156. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 157. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 158. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 159. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 160. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 161. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 162. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 163. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 164. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 165. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 166. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 167. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 168. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 169. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 170. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L
Table 171. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 172. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 173. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 174. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 175. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 176. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 177. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 178. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 179. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 180. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 181. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 182. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209 Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216 Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217 Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233 Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236 Leading 10 Anti-Snoring Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 237. Apnea Sciences Corporation Profile 2020 (CEO, HQ, Founded, Website)
Table 238. Apnea Sciences Corporation Anti-Snoring Treatment Selected Recent Contracts 2020 (Date, Programme Type, Details)
Table 239. Apnea Sciences Corporation Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 240. Medtronic Plc Profile 2020 (CEO, HQ, Founded, Website)
Table 241. Medtronic Plc Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 242. ASF Medical GmbH (Tomed GmbH) Profile 2020 (CEO, HQ, Founded, Website)
Table 243. ASF Medical GmbH (Tomed GmbH) Anti-Snoring Treatment Selected Recent Contracts 2017-2020 (Date, Programme Type, Details)
Table 244. ASF Medical GmbH (Tomed GmbH). Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 245. Bristol-Myers Squibb Company Profile 2020 (CEO, HQ, Founded, Website)
Table 246. Bristol-Myers Squibb Company Selected Recent Contracts 2015-2020 (Date, Programme Type, Details)
Table 247. Bristol-Myers Squibb Company Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 248. Fisher & Paykel Healthcare Limited Profile 2020 (CEO, HQ, Founded, Website)
Table 249. Fisher & Paykel Healthcare Limited Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 250. Koninklijke Philips NV Profile 2020 (CEO, HQ, Founded, Website)
Table 251. Koninklijke Philips NV Anti-Snoring Treatment Selected Recent Contracts 2015-2020 (Date, Programme Type, Details)
Table 252 Koninklijke Philips NV Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 253. Meditas Ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 254. Meditas Ltd Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 255. Meditas Ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 256. Meditas Ltd Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 257. Whole You Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 258. Whole You Inc. Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 259. ResMed Corp Profile 2020 (CEO, Total Company Sales US $m, HQ, Founded, No. of Employees, Ticker, Website)
Table 260. ResMed Corp Total Company Sales 2015-2019 (US $m, AGR %)
Table 261. ResMed Corp Product Offering (Segment, Product Offerings)
Table 262. Other Companies Involved in the Anti-Snoring Treatment Market (Company, Location)
LIST OF FIGURES
Figure 1. Anti-Snoring Treatment Market Overview
Figure 2. Anti-Snoring Treatment Market By Devices Overview
Figure 3. Anti-Snoring Treatment Market By Surgery Overview
Figure 4. Anti-Snoring Treatment Market End User Overview
Figure 5 Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 6. Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 7. Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 8. Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 9. Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 10. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 11. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 12. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 13. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 14. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 15. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 17. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 18. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 19. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 20. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 21. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 22. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 23. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 24. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 25. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 26. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 27. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 28. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 29. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 30. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 31. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 32. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 33. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 34. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 35. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 36. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 37. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 38. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 39. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 40. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 41. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 42. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 43. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 44. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 45. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (Before COVID)
Figure 46. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 47. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 48. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 49. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 50. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %)
Figure 51. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 52. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 53. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 54. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 55. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %)
Figure 56. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 57. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 58. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 59. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 60. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 61. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 62. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 63. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 64. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 65. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 66. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 67. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 68. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 69. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 70. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 71. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 72. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 73. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 74. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 75. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M)
Figure 76. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario V)
Figure 77. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario U)
Figure 78. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario W)
Figure 79. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario L)
Figure 80. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (Before COVID)
Figure 81. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 82. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 83. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 84. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 85. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 86. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 87. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 88. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 89. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 90. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 91. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 92. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 93. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 94. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 95. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 96. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 97. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 98. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 99. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 100. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 101. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 102. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 103. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 104. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 105. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 106. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 107. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 108. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 109. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 110. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 111. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 112. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 113. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 114. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 115 Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (Before COVID)
Figure 116. Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario V)
Figure 117. Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario U)
Figure 118. Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario W)
Figure 119. Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario L)
Figure 120. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M)
Figure 121. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 122. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 123. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 124. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 125. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M)
Figure 126. Asia-Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 127. Asia-Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 128. Asia-Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 129. Asia-Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 130. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 131. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 132. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 133. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 134. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 135. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 136. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 137. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 138 China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 139. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 140. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 141. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 142. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 143. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 144. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 145. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 146. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 147. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 148. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 149. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 150. Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 151. Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 152 Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 153. Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 154. Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 155. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M)
Figure 156. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario V)
Figure 157. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario U)
Figure 158. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario W)
Figure 159. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario L)
Figure 160. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M)
Figure 161. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 162 Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 163. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 164. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 165. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M)
Figure 166. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 167. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 168. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 169. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 170. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 171. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 172. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 173. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 174. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 175. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M)
Figure 176. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario V)
Figure 177. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario U)
Figure 178. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario W)
Figure 179. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario L)
Figure 180. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M)
Figure 181. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 182. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 183. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 184. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 185. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M)
Figure 186. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 187. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 188. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 189. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 190. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 191. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 192. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 193. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 194. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 195. Porter’s Five Force Analysis
Companies Mentioned
1. Apnea Sciences Corporation
2. Medtronic Plc
3. ASF Medical GmbH (Tomed GmbH)
4. Fisher & Paykel Healthcare Limited
5. Koninklijke Philips NV
6. Meditas Ltd.
7. Whole You Inc.
8. ResMed Corp.
9. SomnoMed Limited
10. The Pure Sleep Company
11. Theravent Inc.
12. Medcaptain Medical Technology Co.,
13. GlaxoSmithKline plc
14. Sleeping Well, LLC
15. HoMedics Group Canada Co
16. Sleep Well Enjoy Life, Ltd.
17. Contour Products, Inc.
18. MPowRx Health & Wellness Products Inc.
19. Innovative Health Technologies (NZ) Ltd
20. Tevigo GmbH.
21. Fishpond Ltd.
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Global Anti-Snoring Treatment Market
2.1. Anti-Snoring Treatment Market Definition
2.2. By devices Submarkets Definitions
2.3. By Surgery Submarkets Definitions
2.4. By End user Submarkets Definitions
3. Global Anti-Snoring Treatment Market Overview
3.1. Global Anti-Snoring Treatment Market Size and Forecast by Region
3.2. Global Anti-Snoring Treatment Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Advancement of Anti-Snoring Devices.
3.3.1.2. Increasing Incident and Prevalence Rate of Sleeping Disorders
3.3.1.3. Rising Obesity and Geriatric Population.
3.3.1.4. Excessive Consumption Smoking and Alcohol.
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of Anti-Snoring Devices and Surgery
3.3.2.2. Limited Efficacy of Current Snoring Treatments Available in the Market
3.3.3. Opportunities
3.3.3.1. Increasing Awareness About Sleep Apnea and Treatment.
3.3.3.2. Increasing Development of Anti-Snoring Treatment.
3.3.4. Porter’s Five Forces Analysis
3.3.4.1. Competitive Rivalry
3.3.4.2. Supplier Power
3.3.4.3. Buyer Power
3.3.4.4. Threat of Substitution
3.3.4.5. Threat of New Entry
4. Global Anti-Snoring Treatment Market Analysis and Forecast 2021-2031, By devices (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.2. Mandibular Advancement devices
4.3. Tongue Stabilizing Devices
4.4. Continuous Positive Airway Devices
4.5. Others
5. Global Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 By Surgery (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Radiofrequency Palatoplasty
5.1.1.1. Radiofrequency Palatoplasty Shrinks and Stiffens Soft Palate and Uvula.
5.1.2. Uvulopalatopharyngoplasty (UPPP)
5.1.2.1. Cost Effective Surgical Procedure.
5.1.3. Tonsillectomy
5.1.3.1. Increasingly Adopted Around the Globe to Treat Infection, Inflammation of the Tonsils and for Sleep Disorder.
5.1.4. Laser-assisted Uvulopalatoplasty
5.1.4.1. Prevents from Hospitalization and General Anesthesia
5.1.5. Others
6. Global Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 by End User (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Hospitals
6.1.2. Retail Pharmacies
6.1.3. Others
7. North America Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Anti-Snoring Treatment Market Size and Forecast By devices
7.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
7.3. North America Anti-Snoring Treatment Market Size and Forecast By Surgery
7.3.1. Uvulopalatopharyngoplasty Submarket to Grow at Significant Rate
7.4. North America Anti-Snoring Treatment Market Size and Forecast by end user
7.4.1. Hospitals Submarket to Grow at Significant Rate
7.5. U.S. Anti-Snoring Treatment Market
7.5.1. Increasing Demand for Anti-Snoring Devices
7.6. Canada Anti-Snoring Treatment Market
8. Europe Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Anti-Snoring Treatment Market Size and Forecast By devices
8.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
8.3. Europe Anti-Snoring Treatment Market Size and Forecast By Application
8.3.1. Uvulopalatopharyngoplasty Submarket to Grow At Significant Rate
8.4. Europe Anti-Snoring Treatment Market Size and Forecast By End User
8.4.1. Hospitals Submarket to Grow at Significant Rate
8.5. UK Anti-Snoring Treatment Market
8.5.1. Increasing Demand for Anti-Snoring Devices in The Region
8.6. Germany Anti-Snoring Treatment Market
8.6.1. Rising Awareness for Snoring Treatment and Its Devices.
8.7. France Anti-Snoring Treatment Market
8.7.1. High Alcohol Consumption Rates in the Region.
8.8. Rest of Europe Anti-Snoring Treatment Market
9. Asia Pacific Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Anti-Snoring Treatment Market Size and Forecast By devices
9.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
9.3. Asia Pacific Anti-Snoring Treatment Market Size and Forecast By Surgery
9.3.1. Uvulopalatopharyngoplasty Submarket to Grow at Significant Rate
9.4. Asia Pacific Anti-Snoring Treatment Market Size and Forecast By End User
9.4.1. Increasing Adoption of Devices and Awareness About Sleep Apnea.
9.5. China Anti-Snoring Treatment Market
9.5.1. Prevalence of Smoking and Geriatric Population in the Region
9.6. India Anti-Snoring Treatment Market
9.6.1. Increasing Number of New Cancer Cases
9.7. Japan Anti-Snoring Treatment Market
9.7.1. Change in Lifestyle and Tobacco Smoking Contributing to Increase Anti-Snoring Treatment Demand.
9.8. Rest Of Asia Pacific Anti-Snoring Treatment Market
10. Latin America Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Anti-Snoring Treatment Market Size and Forecast By devices
10.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
10.3. Latin America Anti-Snoring Treatment Market Size and Forecast By Application
10.3.1. Uvulopalatopharyngoplasty Submarket to Grow at Significant Rate
10.4. Latin America Anti-Snoring Treatment Market Size and Forecast by End User
10.4.1. Brazil Anti-Snoring Treatment Market
10.4.1.1. Increasing Prevalence of Snoring in Older Population.
10.4.2. Mexico Anti-Snoring Treatment Market
10.4.2.1. High Prevalence of Snoring/Sleepiness/Observed Apneas in Mexican Population.
10.4.3. Rest Of Latin America Anti-Snoring Treatment Market
10.4.3.1. Increasing Demand for Anti-Snoring Devices.
11. MEA Anti-Snoring Treatment Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. MEA Anti-Snoring Treatment Market Size and Forecast By devices
11.2.1. Continuous Positive Airway Pressure Devices Submarket Expected to Grow at Significant Rate
11.3. MEA Anti-Snoring Treatment Market Size and Forecast By Application
11.3.1. Uvulopalatopharyngoplasty Submarket to Grow at Significant Rate
11.4. MEA Anti-Snoring Treatment Market Size and Forecast by end user
11.5. South Africa Anti-Snoring Treatment Market
11.5.1.1. High Consumption of Alcohol in The Region.
11.6. Rest Of MEA Anti-Snoring Treatment Market
11.6.1.1. Increasingly Healthcare Awareness and Demand for Devices.
12. Companies in the Anti-Snoring Treatment Market
12.1. Apnea Sciences Corporation
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2020)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2020
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2017-2020)
12.2. Medtronic Plc
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2020)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2020
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2017-2020)
12.3. ASF Medical GmbH (Tomed GmbH)
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2020)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2020
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2017-2020)
12.4. Fisher & Paykel Healthcare Limited
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2020)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2020
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2017-2020)
12.5. Koninklijke Philips NV
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2020)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2020
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2017-2020)
12.6. Meditas Ltd
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2020)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2020
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2017-2020)
12.7. Whole You Inc.
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2020)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2020
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2017-2020)
12.8. ResMed Corp.
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2020)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2020
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2017-2020)
12.9. SomnoMed
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2020)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2020
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2017-2020)
12.10. The Pure Sleep Company
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2020)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2020
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2017-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Anti-Snoring Treatment Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Anti-Snoring Treatment Market Drivers & Restraints 2021
Table 7. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Mandibular Advancement devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Tongue Stabilizing Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Continuous Positive Airway Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Anti-Snoring Treatment Submarket Forecast By Surgery 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Radiofrequency Palatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Uvulopalatopharyngoplasty (UPPP) Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49 Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Tonsillectomy Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Laser-assisted Uvulopalatoplasty Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 61. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 62. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 63. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 64. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 65. Anti-Snoring Treatment Market Forecast by end user 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 66. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 67. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 68. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 69. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 70. Hospitals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 71. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 72. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 73. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 74. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 75. Retail Pharmacies Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 76. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 77. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 78. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 79. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 80. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 81. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 82. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 83. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 84. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 85. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 86. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 87. North America Anti-Snoring Treatment Market Forecast By devices2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 88. North America Anti-Snoring Treatment Market Forecast By devices2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 89. North America Anti-Snoring Treatment Market Forecast By devices2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 90. North America Anti-Snoring Treatment Market Forecast By devices2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 91. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 92. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 93. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 94. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 95. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 96. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 97. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031(US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 98. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 99. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 100. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 101. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 102. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 103. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 104. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 105. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 106. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 107. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 108. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 109. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 110. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 111. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 112. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 113. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 114. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %CAGR %) (COVID - Scenario W)
Table 115. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 116. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 117. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 118. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 119. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 120. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 121. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 122. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 123. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 124. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 125. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 126. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 127. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 128. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 129. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 130. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 131. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 132. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 133. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 134. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 135. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 136. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 137. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 138. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 139. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 140. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 141. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 142. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 143. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 144. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 145. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 146. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 147. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 148. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR % CAGR %) (Before COVID)
Table 149. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR % CAGR %), (COVID - Scenario W)
Table 150. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 151. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 152. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 153. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 154. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR%, CAGR %) (COVID - Scenario W)
Table 155. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 156. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 157. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 158. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 159. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 160. Asia Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 161. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 162. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 163. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 164. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 165. Asia Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 166. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 167. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 168. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 169. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 170. Asia Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L
Table 171. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 172. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 173. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 174. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 175. Asia Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 176. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 177. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 178. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 179. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 180. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 181. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 182. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 183. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 184. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 185. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 186. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 187. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 188. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 189. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 200. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 201. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 202. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 203. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 204. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 205. RoAPAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 206. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 207. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 208. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 209 Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 210. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 211. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 212. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 213. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 214. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 215. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 216 Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 217 Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 218. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 219. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 220. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 221. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 222. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 223. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 224. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 225. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 226. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 227. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 228. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 229. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 230. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 231. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 232. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 233 Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 234. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 235. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 236 Leading 10 Anti-Snoring Treatment Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 237. Apnea Sciences Corporation Profile 2020 (CEO, HQ, Founded, Website)
Table 238. Apnea Sciences Corporation Anti-Snoring Treatment Selected Recent Contracts 2020 (Date, Programme Type, Details)
Table 239. Apnea Sciences Corporation Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 240. Medtronic Plc Profile 2020 (CEO, HQ, Founded, Website)
Table 241. Medtronic Plc Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 242. ASF Medical GmbH (Tomed GmbH) Profile 2020 (CEO, HQ, Founded, Website)
Table 243. ASF Medical GmbH (Tomed GmbH) Anti-Snoring Treatment Selected Recent Contracts 2017-2020 (Date, Programme Type, Details)
Table 244. ASF Medical GmbH (Tomed GmbH). Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 245. Bristol-Myers Squibb Company Profile 2020 (CEO, HQ, Founded, Website)
Table 246. Bristol-Myers Squibb Company Selected Recent Contracts 2015-2020 (Date, Programme Type, Details)
Table 247. Bristol-Myers Squibb Company Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 248. Fisher & Paykel Healthcare Limited Profile 2020 (CEO, HQ, Founded, Website)
Table 249. Fisher & Paykel Healthcare Limited Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 250. Koninklijke Philips NV Profile 2020 (CEO, HQ, Founded, Website)
Table 251. Koninklijke Philips NV Anti-Snoring Treatment Selected Recent Contracts 2015-2020 (Date, Programme Type, Details)
Table 252 Koninklijke Philips NV Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 253. Meditas Ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 254. Meditas Ltd Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 255. Meditas Ltd Profile 2020 (CEO, HQ, Founded, Website)
Table 256. Meditas Ltd Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 257. Whole You Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 258. Whole You Inc. Anti-Snoring Treatment Product Offering (Segment, Product Offerings)
Table 259. ResMed Corp Profile 2020 (CEO, Total Company Sales US $m, HQ, Founded, No. of Employees, Ticker, Website)
Table 260. ResMed Corp Total Company Sales 2015-2019 (US $m, AGR %)
Table 261. ResMed Corp Product Offering (Segment, Product Offerings)
Table 262. Other Companies Involved in the Anti-Snoring Treatment Market (Company, Location)
LIST OF FIGURES
Figure 1. Anti-Snoring Treatment Market Overview
Figure 2. Anti-Snoring Treatment Market By Devices Overview
Figure 3. Anti-Snoring Treatment Market By Surgery Overview
Figure 4. Anti-Snoring Treatment Market End User Overview
Figure 5 Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 6. Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 7. Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 8. Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 9. Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 10. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 11. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 12. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 13. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 14. Anti-Snoring Treatment Submarket Forecast By devices 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 15. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID – Scenario V)
Figure 17. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 18. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 19. Continuous Positive Airway Pressure Devices Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 20. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 21. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 22. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 23. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 24. Anti-Snoring Treatment Submarket Forecast By Application 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 25. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 26. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 27. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 28. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 29. Uvulopalatopharyngoplasty Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 30. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 31. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 32. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 33. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 34. Anti-Snoring Treatment Submarket Forecast by end user 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 35. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 36. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario V)
Figure 37. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 38. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 39. Hospital Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 40. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 41. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 42. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 43. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 44. Regional Anti-Snoring Treatment Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 45. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (Before COVID)
Figure 46. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 47. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 48. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 49. North America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 50. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %)
Figure 51. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 52. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 53. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 54. North America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 55. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %)
Figure 56. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 57. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 58. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 59. North America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 60. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 61. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 62. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 63. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 64. North America Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 65. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 66. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 67. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 68. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 69. US Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 70. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 71. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 72. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 73. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 74. Canada Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 75. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M)
Figure 76. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario V)
Figure 77. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario U)
Figure 78. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario W)
Figure 79. Europe Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario L)
Figure 80. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (Before COVID)
Figure 81. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 82. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 83. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 84. Europe Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 85. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (Before COVID)
Figure 86. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 87. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 88. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 89. Europe Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 90. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 91. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 92. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 93. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 94. Europe Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 95. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 96. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 97. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 98. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 99. UK Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 100. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 101. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 102. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 103. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 104. Germany Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 105. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 106. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 107. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 108. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 109. France Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 110. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 111. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 112. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 113. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 114. Rest of Europe Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 115 Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (Before COVID)
Figure 116. Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario V)
Figure 117. Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario U)
Figure 118. Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario W)
Figure 119. Asia-Pacific Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario L)
Figure 120. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M)
Figure 121. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 122. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 123. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 124. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 125. Asia-Pacific Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M)
Figure 126. Asia-Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 127. Asia-Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 128. Asia-Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 129. Asia-Pacific Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 130. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 131. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 132. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 133. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 134. Asia-Pacific Anti-Snoring Treatment Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 135. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 136. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 137. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 138 China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 139. China Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 140. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 141. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 142. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 143. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 144. India Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 145. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 146. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 147. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 148. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 149. Japan Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 150. Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 151. Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 152 Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 153. Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 154. Rest of APAC Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 155. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M)
Figure 156. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario V)
Figure 157. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario U)
Figure 158. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario W)
Figure 159. Middle East Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario L)
Figure 160. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M)
Figure 161. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 162 Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 163. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 164. Middle East Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 165. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M)
Figure 166. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 167. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 168. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 169. Middle East Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 170. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 171. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 172. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 173. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 174. Rest of Middle East Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 175. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M)
Figure 176. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario V)
Figure 177. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario U)
Figure 178. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario W)
Figure 179. Latin America Anti-Snoring Treatment Market Forecast By devices 2021-2031 (US$M) (COVID - Scenario L)
Figure 180. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M)
Figure 181. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario V)
Figure 182. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario U)
Figure 183. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario W)
Figure 184. Latin America Anti-Snoring Treatment Market Forecast By Application 2021-2031 (US$M) (COVID - Scenario L)
Figure 185. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M)
Figure 186. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario V)
Figure 187. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario U)
Figure 188. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario W)
Figure 189. Latin America Anti-Snoring Treatment Market Forecast by End User 2021-2031 (US$M) (COVID - Scenario L)
Figure 190. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %)
Figure 191. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 192. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 193. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 194. Rest of Latin America Anti-Snoring Treatment Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 195. Porter’s Five Force Analysis
Companies Mentioned
1. Apnea Sciences Corporation
2. Medtronic Plc
3. ASF Medical GmbH (Tomed GmbH)
4. Fisher & Paykel Healthcare Limited
5. Koninklijke Philips NV
6. Meditas Ltd.
7. Whole You Inc.
8. ResMed Corp.
9. SomnoMed Limited
10. The Pure Sleep Company
11. Theravent Inc.
12. Medcaptain Medical Technology Co.,
13. GlaxoSmithKline plc
14. Sleeping Well, LLC
15. HoMedics Group Canada Co
16. Sleep Well Enjoy Life, Ltd.
17. Contour Products, Inc.
18. MPowRx Health & Wellness Products Inc.
19. Innovative Health Technologies (NZ) Ltd
20. Tevigo GmbH.
21. Fishpond Ltd.
Companies Profiled in the Report
1. Apnea Sciences Corporation
2. Medtronic, Plc
3. ASF Medical GmbH (Tomed GmbH)
4. Fisher & Paykel Healthcare Limited
5. Koninklijke Philips N.V.
6. Meditas Ltd
7. Whole You Inc.
8. ResMed Corp.
9. SomnoMed
10. The Pure Sleep Company
11. Theravent Inc.
12. Medcaptain Medical Technology Co.,
13. GlaxoSmithKline plc
List of Companies Mentioned in the Report:
1. Apnea Sciences Corporation
2. Medtronic, Plc
3. ASF Medical GmbH (Tomed GmbH)
4. Fisher & Paykel Healthcare Limited
5. Koninklijke Philips N.V.
6. Meditas Ltd.
7. Whole You Inc.
8. ResMed Corp.
9. SomnoMed Limited
10. The Pure Sleep Company
11. Theravent Inc.
12. Medcaptain Medical Technology Co.,
13. GlaxoSmithKline plc
14. Sleeping Well, LLC
15. HoMedics Group Canada Co
16. Sleep Well Enjoy Life, Ltd.
17. Contour Products, Inc.
18. MPowRx Health & Wellness Products Inc.
19. Innovative Health Technologies (NZ) Ltd
20. Tevigo GmbH.
21. Fishpond Ltd.
List of Organizations Mentioned in the Report
1. World Health Organization
2. Sleep Foundation
3. US Food & Drug Administration
4. US National Library of Medicine
5. National Institutes of Health
6. National Association for Biomedical Research
7. CDC (Center for Disease Control and Prevention)
8. National Institute of Food and Agriculture (NIFA)
9. The Food & Agriculture Organisation
10. NCBI
11. Mayo Clinic
12. Indian Medical Association
13. Medline Plus
14. National Institute on Alcohol Abuse and Alcoholism
15. American Sleep Apnea Association
16. Help Guide
17. Sleep Education
18. Cleveland Clinic
19. British Snoring & Sleep Apnoea Association
20. National Sleep Foundation
1. Apnea Sciences Corporation
2. Medtronic, Plc
3. ASF Medical GmbH (Tomed GmbH)
4. Fisher & Paykel Healthcare Limited
5. Koninklijke Philips N.V.
6. Meditas Ltd
7. Whole You Inc.
8. ResMed Corp.
9. SomnoMed
10. The Pure Sleep Company
11. Theravent Inc.
12. Medcaptain Medical Technology Co.,
13. GlaxoSmithKline plc
List of Companies Mentioned in the Report:
1. Apnea Sciences Corporation
2. Medtronic, Plc
3. ASF Medical GmbH (Tomed GmbH)
4. Fisher & Paykel Healthcare Limited
5. Koninklijke Philips N.V.
6. Meditas Ltd.
7. Whole You Inc.
8. ResMed Corp.
9. SomnoMed Limited
10. The Pure Sleep Company
11. Theravent Inc.
12. Medcaptain Medical Technology Co.,
13. GlaxoSmithKline plc
14. Sleeping Well, LLC
15. HoMedics Group Canada Co
16. Sleep Well Enjoy Life, Ltd.
17. Contour Products, Inc.
18. MPowRx Health & Wellness Products Inc.
19. Innovative Health Technologies (NZ) Ltd
20. Tevigo GmbH.
21. Fishpond Ltd.
List of Organizations Mentioned in the Report
1. World Health Organization
2. Sleep Foundation
3. US Food & Drug Administration
4. US National Library of Medicine
5. National Institutes of Health
6. National Association for Biomedical Research
7. CDC (Center for Disease Control and Prevention)
8. National Institute of Food and Agriculture (NIFA)
9. The Food & Agriculture Organisation
10. NCBI
11. Mayo Clinic
12. Indian Medical Association
13. Medline Plus
14. National Institute on Alcohol Abuse and Alcoholism
15. American Sleep Apnea Association
16. Help Guide
17. Sleep Education
18. Cleveland Clinic
19. British Snoring & Sleep Apnoea Association
20. National Sleep Foundation
Download sample pages
Complete the form below to download your free sample pages for Anti-snoring Market Report to 2031Related reports
-
Nasal Drug Delivery Technology Market Report 2022-2032
The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease...Full DetailsPublished: 18 January 2022 -
Topical Drug Delivery Market Report 2020-2030
Delivery of biologics through the transdermal route is anticipated to open new avenues for the manufacturers of topical drugs. Transdermal...Full DetailsPublished: 22 October 2020 -
Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031
Rising prevalence of chronic respiratory diseases including asthma, COPD, and allergic rhinitis; rising geriatric population, escalating investment in drug R&D...Full DetailsPublished: 22 March 2021 -
Sleep Apnea Devices Market Report 2019-2029
Where is the Sleep Apnea market heading? If you are involved in this sector you must read this newly updated...
Full DetailsPublished: 01 January 1970 -
Sleep Tech Market Report 2023-2033
The global Sleep Tech market is projected to grow at a CAGR of 22.6% by 2033...Full DetailsPublished: 03 March 2023 -
Drug Delivery Technologies Market Report 2021-2031
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand...Full DetailsPublished: 13 July 2021
Download sample pages
Complete the form below to download your free sample pages for Anti-snoring Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034
The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.
11 April 2024
Visiongain Publishes Female Health Tech Market Report 2024-2034
The global Female Health Tech market was estimated to be valued at US$ 140.9 billion in 2034 and is expected to register a CAGR of 9.6% from 2024 to 2034.
05 April 2024
Visiongain Publishes Meningococcal Vaccines Market Report 2024-2034
The global Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034
26 March 2024
